EyePoint Pharmaceuticals Inc (EYPT)
11.47
-0.12
(-1.04%)
USD |
NASDAQ |
May 22, 16:00
11.47
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -216.20M |
September 30, 2023 | -9.974M |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | -108.48M |
September 30, 2021 | 7.317M |
June 30, 2021 | 0.001M |
March 31, 2021 | -115.67M |
December 31, 2020 | -25.12M |
September 30, 2020 | -4.812M |
June 30, 2020 | 0.295M |
March 31, 2020 | -20.28M |
December 31, 2019 | -1.872M |
September 30, 2019 | -2.412M |
June 30, 2019 | -18.34M |
March 31, 2019 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | -25.20M |
March 31, 2018 | -9.266M |
December 31, 2017 | -6.081M |
September 30, 2017 | -0.963M |
Date | Value |
---|---|
June 30, 2017 | -6.099M |
March 31, 2017 | -2.305M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.01M |
March 31, 2016 | -16.51M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | 0.092M |
March 31, 2014 | -7.005M |
December 31, 2013 | -1.163M |
September 30, 2013 | -9.981M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.066M |
September 30, 2012 | -4.735M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.036M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-216.20M
Minimum
Dec 2023
7.317M
Maximum
Sep 2021
-34.37M
Average
-4.812M
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
Nanoviricides Inc | -- |
Bio-Path Holdings Inc | -0.174M |
GlycoMimetics Inc | 0.00 |
Ocular Therapeutix Inc | -316.35M |
Aileron Therapeutics Inc | -- |